← FDA Drug Approvals (Drugs@FDA)

NDA212427

NDA · New Drug Application · Sponsor: HETERO LABS LTD III · Approved 2024-01-18

Drug application

FDA Application #

NDA212427

Application type

New Drug Application

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

HETERO LABS LTD III

First approval

2024-01-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown